疑似ATTR心脏淀粉样变患者99mTc-DPD SPECT/CT定量评估的可行性与视觉评分相关性
Perugini评分2与3患者间定量值重叠明显。结论认为定量99mTc-DPD SPECT/CT可行,可更准确评估心肌摄取。
要点
- 99mTc-DPD SPECT/CT定量心肌摄取在疑似ATTR CA患者中可行。
- 心肌SUVmax、SUVpeak及骨归一化值与Perugini评分呈较强相关。
- Perugini评分2与3患者间定量值存在较大重叠。
核心结论
- 定量99mTc-DPD SPECT/CT在疑似ATTR CA患者中可行,能更准确评估心肌摄取。
研究设计与样本
- 回顾性研究,连续纳入患者行99mTc-DPD全身骨显像及胸部SPECT/CT,用XSPECT-QUANT软件定量心脏DPD摄取。
主要发现
- Perugini评分2与3患者间定量值存在较大程度重叠。
临床怎么用
- 在疑似ATTR CA患者中可尝试用SPECT/CT定量心肌DPD摄取辅助评估。
- 定量值需结合Perugini视觉评分解读,注意评分2与3间重叠。
局限性
- Perugini评分2与3患者间定量值重叠明显,鉴别价值有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While a visual interpretation of 99mTc-DPD scintigraphy by means of Perugini score can provide a reliable diagnosis of transthyretin-related (ATTR) cardiac amyloidosis (CA), a quantitative approach is expected to play a major role in risk stratification and therapy evaluation. The aim of our study was to test the feasibility of a quantitative assessment and to correlate various parameters to Perugini score. METHODS: in this retrospective study, consecutive patients underwent a 99mTc-DPD whole-body bone scintigraphy and a SPECT/CT of the thorax. XSPECT-QUANT software was used to quantify the DPD uptake in the heart. RESULTS: Thirteen patients were included. CA was confirmed in 8 and rejected in 5. Myocardial SUVmax and SUVpeak showed a fairly strong correlation with Perugini score (both ρ = .71, P = .006). Same held true for to-bone normalized values (both ρ = .75, P = .003). There was a great degree of overlap for quantitative values in patients with Perugini score 2 and 3. CONCLUSION: Quantitative 99mTc-DPD SPECT/CT in suspected ATTR CA patients is feasible and allows for a more accurate assessment of myocardial uptake.
引用
- Caobelli F, Braun M, Haaf P, et al. Quantitative 99mTc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores. J Nucl Cardiol. 2019. PMID: 31538322. doi:10.1007/s12350-019-01893-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。